Literature DB >> 22695459

Control of hypertension among adults--National Health and Nutrition Examination Survey, United States, 2005-2008.

Paula W Yoon1, Cathleen D Gillespie, Mary G George, Hilary K Wall.   

Abstract

Cardiovascular disease (CVD) is the leading cause of preventable death in the United States, and approximately 1 million heart attacks and 700,000 strokes occur annually. Hypertension is a major risk factor for cardiovascular disease and stroke; the unadjusted prevalence of hypertension among U.S. adults aged ≥18 years is approximately 31% (representing 68 million adults), and hypertension increases with age to approximately 70% among persons aged ≥65 years. Hypertension contributes to one out of every seven deaths in the United States, and approximately 70% of persons who have a first heart attack or stroke or who have heart failure have hypertension. In clinical trials, treatment of hypertension was associated with substantial reductions in stroke incidence (35%-40%), myocardial infarction (20%-25%), and heart failure (>50%). The estimated annual direct costs of hypertension are approximately $69.9 billion, and the estimated annual indirect costs are $23.6 billion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22695459

Source DB:  PubMed          Journal:  MMWR Suppl        ISSN: 2380-8942


  23 in total

1.  Who Are the Undiagnosed? Disparities in Hypertension Diagnoses in Vulnerable Populations.

Authors:  Margaret Meador; Joy H Lewis; R Curtis Bay; Hilary K Wall; Chanaye Jackson
Journal:  Fam Community Health       Date:  2020 Jan/Mar

2.  Association of medical treatment nonadherence with all-cause mortality in newly treated hypertensive US veterans.

Authors:  Elvira O Gosmanova; Jun L Lu; Elani Streja; William C Cushman; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Hypertension       Date:  2014-08-04       Impact factor: 10.190

3.  Social relationships and hypertension in late life: evidence from a nationally representative longitudinal study of older adults.

Authors:  Yang Claire Yang; Courtney Boen; Kathleen Mullan Harris
Journal:  J Aging Health       Date:  2014-09-23

4.  Disparities in access to care among US adults with self-reported hypertension.

Authors:  Jing Fang; Quanhe Yang; Carma Ayala; Fleetwood Loustalot
Journal:  Am J Hypertens       Date:  2014-05-21       Impact factor: 2.689

5.  Differences and similarities in explanatory models of hypertension in the United States of america, Tanzania and Jamaica.

Authors:  J D Purakal; J Williams-Johnson; E W Williams; S Pemba; J Kambona; R Welch; J Flack; P Levy
Journal:  West Indian Med J       Date:  2014-06-11       Impact factor: 0.171

6.  Use of multiple data sources and individual case investigation to refine surveillance-based estimates of the HIV care continuum.

Authors:  Julia C Dombrowski; Susan E Buskin; Amy Bennett; Hanne Thiede; Matthew R Golden
Journal:  J Acquir Immune Defic Syndr       Date:  2014-11-01       Impact factor: 3.731

7.  Role of health insurance and neighborhood-level social deprivation on hypertension control following the affordable care act health insurance opportunities.

Authors:  Angier H; Green Bb; Fankhauser K; Marino M; Huguet N; Larson A; DeVoe Je
Journal:  Soc Sci Med       Date:  2020-10-31       Impact factor: 4.634

Review 8.  Dendritic cells and isolevuglandins in immunity, inflammation, and hypertension.

Authors:  Kala B Dixon; Sean S Davies; Annet Kirabo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-12-16       Impact factor: 4.733

Review 9.  Understanding the Importance of Race/Ethnicity in the Care of the Hypertensive Patient.

Authors:  Keith C Ferdinand; Samar A Nasser
Journal:  Curr Hypertens Rep       Date:  2015-03       Impact factor: 5.369

Review 10.  Ion channel remodeling in vascular smooth muscle during hypertension: Implications for novel therapeutic approaches.

Authors:  Biny K Joseph; Keshari M Thakali; Christopher L Moore; Sung W Rhee
Journal:  Pharmacol Res       Date:  2013-01-31       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.